Home
About
Publications Trends
Recent Publications
Expert Search
Archive
cost minimization analysis (cma)
When is CMA Applicable?
CMA is appropriate when the interventions being compared have demonstrated equivalent clinical effectiveness. This equivalence must be established through rigorous
clinical trials
or epidemiological studies. If the outcomes are not equivalent, other forms of economic evaluations such as
cost-effectiveness analysis (CEA)
,
cost-utility analysis (CUA)
, or
cost-benefit analysis (CBA)
would be more suitable.
Frequently asked queries:
When is CMA Applicable?
How to Conduct a CMA?
What are the Major Types of TSEs?
Why Use In-Memory Databases in Epidemiology?
What Challenges Does NHSN Face?
How is Gene Expression Measured?
How Do Antiviral Therapies Work?
How Does the ECDC Function?
How Do Public Health Nurses Influence Health Policy?
How Does Diversity Impact Data Collection and Analysis?
What is Mortality in Epidemiology?
What Are Some Challenges Faced by Epidemiologists in the Superfund Program?
How is Exposure to Silica Dust Controlled?
What Strategies Can Be Implemented to Improve Air Quality?
What are the Challenges in Identifying the Source?
What is Point Data?
How is High Risk Determined?
What is the Role of Environmental Factors?
Why are Discriminators Important?
What are the common types of questions used in epidemiological studies?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Andes Virus
COVID-19 Patients
Field Epidemiology
Genetic Diagnosis
Genetic Variants
Global Health
Public Health Education
Partnered Content Networks
Relevant Topics
active learning
African Populations
Andes virus
APOL1
arrhythmias
blended learning
cardiac complications
Chronic Kidney Disease
COVID-19
Disease Prevention
disease surveillance
emerging diseases
epidemiology
Epidemiology Training Laboratory Diagnostics
Evolutionary Genetics
experiential learning
Field Epidemiology
Field Epidemiology Training Programs
fieldwork
FSGS
genetic counseling
genetic testing
Genetic Variants
global disease monitoring
Global Health Capacity
Global health security
Global Health Security Agenda
H-ESKD
hantavirus
hantavirus pulmonary syndrome
Health Security
heart failure
hereditary paragangliomas
HIF pathway
human-to-human transmission
infectious diseases
internships
Kidney Disease
laboratory networks
Laboratory Training Programs
myocardial injury
myocarditis
Outbreak Investigation
outbreak response
pedagogy
person-to-person transmission
pseudo-hypoxia
Public Health
Public health education
public health infrastructure
public health practice
public health strategies
Public Health Workforce
renal cell carcinoma
respiratory transmission
SDH mutations
Surveillance Systems
technology in education
thromboembolism
tumorigenesis
viral outbreaks
zoonotic diseases
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Epidemiology.
Subscribe